BG

Bellevue Group Portfolio holdings

AUM $4.81B
1-Year Est. Return 29.28%
This Quarter Est. Return
1 Year Est. Return
+29.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.07B
AUM Growth
-$1.54B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
187
New
Increased
Reduced
Closed

Top Buys

1 +$58.1M
2 +$41.4M
3 +$28.1M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$25.4M
5
CLDX icon
Celldex Therapeutics
CLDX
+$24.9M

Top Sells

1 +$98M
2 +$85.7M
3 +$47.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$46.5M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$42.9M

Sector Composition

1 Healthcare 98.26%
2 Industrials 0.38%
3 Energy 0.03%
4 Communication Services 0.01%
5 Technology 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
76
$25.1M 0.35%
303,500
-163,315
77
$24.9M 0.35%
+925,000
78
$24M 0.34%
192,588
-1,066
79
$23.8M 0.34%
362,728
-5,490
80
$23.6M 0.33%
95,984
-1,730
81
$22.5M 0.32%
151,200
+39,434
82
$22.2M 0.31%
572,621
-10,200
83
$21.6M 0.31%
7,325,514
84
$21.4M 0.3%
1,756,307
+5,617
85
$21.2M 0.3%
229,153
-3,202
86
$20.7M 0.29%
941,059
+333,445
87
$19.5M 0.28%
595,380
+309,305
88
$18.8M 0.27%
270,825
-4,958
89
$18.2M 0.26%
579,887
-1,142
90
$18M 0.25%
155,808
-2,352
91
$17.8M 0.25%
84,865
-1,484
92
$17M 0.24%
680,153
+99,655
93
$16M 0.23%
89,299
+8,209
94
$15.8M 0.22%
5,009,714
-25,100
95
$15.6M 0.22%
503,007
-9,209
96
$15.1M 0.21%
519,876
-5,124
97
$14.6M 0.21%
4,494,458
-68,400
98
$13.8M 0.2%
416,112
+52,896
99
$12.4M 0.18%
50,959
-2,841
100
$11.8M 0.17%
2,152,025
-32,400